IDEAS home Printed from https://ideas.repec.org/r/eee/heachp/1-33.html
   My bibliography  Save this item

Economic epidemiology and infectious diseases

In: Handbook of Health Economics

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Luca Gori & Piero Manfredi & Simone Marsiglio & Mauro Sodini, 2022. "COVID‐19 epidemic and mitigation policies: Positive and normative analyses in a neoclassical growth model," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 24(5), pages 968-992, October.
  2. Rikard Forslid & Mathias Herzing, 2015. "On the Optimal Production Capacity for Influenza Vaccine," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 726-741, June.
  3. Wang, Jun & Ang, James B., 2024. "Epidemics, disease control, and China’s long-term development," Journal of Comparative Economics, Elsevier, vol. 52(1), pages 93-112.
  4. Philipson Tomas J & Jena Anupam B, 2006. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," Forum for Health Economics & Policy, De Gruyter, vol. 9(2), pages 1-33, January.
  5. Jérôme Adda, 2016. "Economic Activity and the Spread of Viral Diseases: Evidence from High Frequency Data," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 131(2), pages 891-941.
  6. Adeline Delavande & Dana Goldman & Neeraj Sood, 2007. "Criminal Prosecution and HIV-related Risky Behavior," NBER Working Papers 12903, National Bureau of Economic Research, Inc.
  7. Douglas Gollin & Christian Zimmermann, 2005. "Malaria," 2005 Meeting Papers 561, Society for Economic Dynamics.
  8. Marlène Guillon & Josselin Thuilliez, 2015. "HIV and Rational risky behaviors: a systematic review of published empirical literature (1990-2013)," Post-Print halshs-01222571, HAL.
  9. Auld, M. Christopher & Toxvaerd, Flavio, 2021. "The Great Covid-19 Vaccine Rollout: Behavioural And Policy Responses," National Institute Economic Review, National Institute of Economic and Social Research, vol. 257, pages 14-35, August.
  10. Banri ITO & Tatsufumi YAMAGATA, 2007. "Who Develops Innovations In Medicine For The Poor? Trends In Patent Applications Related To Medicines For Hiv/Aids, Tuberculosis, Malaria, And Neglected Diseases," The Developing Economies, Institute of Developing Economies, vol. 45(2), pages 141-171, June.
  11. Gensowski, Miriam & Nielsen, Torben Heien & Nielsen, Nete Munk & Rossin-Slater, Maya & Wüst, Miriam, 2019. "Childhood health shocks, comparative advantage, and long-term outcomes: Evidence from the last Danish polio epidemic," Journal of Health Economics, Elsevier, vol. 66(C), pages 27-36.
  12. La Torre, Davide & Malik, Tufail & Marsiglio, Simone, 2020. "Optimal control of prevention and treatment in a basic macroeconomic–epidemiological model," Mathematical Social Sciences, Elsevier, vol. 108(C), pages 100-108.
  13. Aureo de Paula & Gil Shapira & Petra E. Todd, 2008. "How Beliefs about HIV Status Affect Risky Behaviors: Evidence from Malawi, Fifth Version," PIER Working Paper Archive 10-023, Penn Institute for Economic Research, Department of Economics, University of Pennsylvania, revised 10 Jul 2010.
  14. Luca Gori & Cristiana Mammana & Piero Manfredi & Elisabetta Michetti, 2022. "Economic development with deadly communicable diseases and public prevention," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 24(5), pages 912-943, October.
  15. Tomas Philipson & Stephane Mechoulan, 2003. "Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets," NBER Working Papers 9598, National Bureau of Economic Research, Inc.
  16. Javier Birchenall, 2007. "Escaping high mortality," Journal of Economic Growth, Springer, vol. 12(4), pages 351-387, December.
  17. Casey B. Mulligan, 2021. "The incidence and magnitude of the health costs of in-person schooling during the COVID-19 pandemic," Public Choice, Springer, vol. 188(3), pages 303-332, September.
  18. Adeline Delavande & Dana Goldman & Neeraj Sood, 2010. "Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior," Journal of Law and Economics, University of Chicago Press, vol. 53(4), pages 741-782.
  19. Cardon, James H. & Eide, Eric R. & Showalter, Mark H., 2024. "Home alone: Evaluating the implications of government mandates and disease prevalence on time usage during the pandemic," Research in Economics, Elsevier, vol. 78(2).
  20. Sumedha Gupta & Kosali I. Simon & Coady Wing, 2020. "Mandated and Voluntary Social Distancing During The COVID-19 Epidemic: A Review," NBER Working Papers 28139, National Bureau of Economic Research, Inc.
  21. Byung-Kwang Yoo & Megumi Kasajima & Jay Bhattacharya, 2010. "Public Avoidance and the Epidemiology of novel H1N1 Influenza A," NBER Working Papers 15752, National Bureau of Economic Research, Inc.
  22. Djemaï, Elodie, 2008. "Is the risk taking of HIV-infection influenced by income uncertainty? : Empirical Evidence from Sub-Saharan Africa," MPRA Paper 11731, University Library of Munich, Germany.
  23. Gardner Brown & Ramanan Laxminarayan, 1998. "Economics of Antibiotic Resistance," Working Papers 0060, University of Washington, Department of Economics.
  24. In Kyung Kim, 2021. "The impact of social distancing on box-office revenue: Evidence from the COVID-19 pandemic," Quantitative Marketing and Economics (QME), Springer, vol. 19(1), pages 93-125, March.
  25. Pichler, Stefan & Ziebarth, Nicolas R., 2017. "The pros and cons of sick pay schemes: Testing for contagious presenteeism and noncontagious absenteeism behavior," Journal of Public Economics, Elsevier, vol. 156(C), pages 14-33.
  26. Abel Brodeur & Warn N Lekfuangfu & Yanos Zylberberg, 2018. "War, Migration and the Origins of the Thai Sex Industry," Journal of the European Economic Association, European Economic Association, vol. 16(5), pages 1540-1576.
  27. Berthélemy, Jean-Claude & Gaudart, Jean & Thuilliez, Josselin, 2015. "Prevention or treatment? The case of malaria," Economics Letters, Elsevier, vol. 131(C), pages 16-19.
  28. Jorge M. Agüero & Trinidad Beleche, 2016. "Health Shocks and the Long-Lasting Change in Health Behaviors: Evidence from Mexico," Working papers 2016-26, University of Connecticut, Department of Economics.
  29. Tomas J. Philipson & Anupam B. Jena, 2005. "Surplus Appropriation from R&D and Health Care Technology Assessment Procedures," Public Economics 0511021, University Library of Munich, Germany.
  30. Hassan, Tarek & Hollander, Stephan & van Lent, Laurence & Schwedeler, Markus & Tahoun, Ahmed, 2020. "Firm-Level Exposure to Epidemic Diseases: Covid-19, SARS, and H1N1," CEPR Discussion Papers 14573, C.E.P.R. Discussion Papers.
  31. Tatsushi Oka & Wei Wei & Dan Zhu, 2020. "A Spatial Stochastic SIR Model for Transmission Networks with Application to COVID-19 Epidemic in China," Papers 2008.06051, arXiv.org, revised Aug 2020.
  32. David E. Bloom & Michael Kuhn & Klaus Prettner, 2022. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
  33. Stefan Pichler & Nicolas R. Ziebarth, 2015. "The Pros and Cons of Sick Pay Schemes: Testing for Contagious Presenteeism and Shirking Behavior," Discussion Papers of DIW Berlin 1509, DIW Berlin, German Institute for Economic Research.
  34. Ko, Hansoo, 2021. "Behavioral responses to the 2015 MERS epidemic in Korea," Economics & Human Biology, Elsevier, vol. 41(C).
  35. Farboodi, Maryam & Jarosch, Gregor & Shimer, Robert, 2021. "Internal and external effects of social distancing in a pandemic," Journal of Economic Theory, Elsevier, vol. 196(C).
  36. Daniel W. Sacks & Nir Menachemi & Peter Embi & Coady Wing, 2020. "What can we learn about SARS-CoV-2 prevalence from testing and hospital data?," Papers 2008.00298, arXiv.org, revised Mar 2021.
  37. Darius Lakdawalla & Neeraj Sood & Dana Goldman, 2006. "HIV Breakthroughs and Risky Sexual Behavior," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 121(3), pages 1063-1102.
  38. Veronica Guerrieri & Guido Lorenzoni & Ludwig Straub & Iván Werning, 2022. "Macroeconomic Implications of COVID-19: Can Negative Supply Shocks Cause Demand Shortages?," American Economic Review, American Economic Association, vol. 112(5), pages 1437-1474, May.
  39. Amarakoon Bandara, 2005. "Emerging health isues in Asia and the Pacific: implications for public health policy," Asia-Pacific Development Journal, United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), vol. 12(2), pages 33-58, December.
  40. Miguel Casares & Paul Gomme & Hashmat Khan, 2022. "COVID‐19 pandemic and economic scenarios for Ontario," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 55(S1), pages 503-539, February.
  41. La Torre, Davide & Marsiglio, Simone & Mendivil, Franklin & Privileggi, Fabio, 2021. "Generalized Fractal Transforms with Condensation: a Macroeconomic-Epidemiological Application," Department of Economics and Statistics Cognetti de Martiis. Working Papers 202107, University of Turin.
  42. Goulão, Catarina & Pérez-Barahona, Agustín, 2011. "Intergenerational transmission of non-communicable chronic diseases," TSE Working Papers 11-219, Toulouse School of Economics (TSE).
  43. Marcella M. Alsan & David M. Cutler, 2010. "Why did HIV decline in Uganda?," NBER Working Papers 16171, National Bureau of Economic Research, Inc.
  44. Myong-Hun Chang & Troy Tassier, 2021. "Spatially Heterogeneous Vaccine Coverage and Externalities in a Computational Model of Epidemics," Computational Economics, Springer;Society for Computational Economics, vol. 58(1), pages 27-55, June.
  45. Laxminarayan, Ramanan & Weitzman, Martin L., 2002. "On the implications of endogenous resistance to medications," Journal of Health Economics, Elsevier, vol. 21(4), pages 709-718, July.
  46. Mark Gersovitz & Jeffrey S. Hammer, 2004. "The Economical Control of Infectious Diseases," Economic Journal, Royal Economic Society, vol. 114(492), pages 1-27, January.
  47. Wei Zhong, 2017. "Simulating influenza pandemic dynamics with public risk communication and individual responsive behavior," Computational and Mathematical Organization Theory, Springer, vol. 23(4), pages 475-495, December.
  48. Rowthorn, Robert & Toxvaerd, Flavio, 2012. "The Optimal Control of Infectious Diseases via Prevention and Treatment," CEPR Discussion Papers 8925, C.E.P.R. Discussion Papers.
  49. Tut, Daniel, 2022. "Investment, Q and epidemic diseases," Finance Research Letters, Elsevier, vol. 47(PB).
  50. Goodkin-Gold, Matthew & Kremer, Michael & Snyder, Christopher M. & Williams, Heidi, 2022. "Optimal vaccine subsidies for endemic diseases," International Journal of Industrial Organization, Elsevier, vol. 84(C).
  51. Troy Tassier & Philip Polgreen & Alberto Segre, 2017. "Network position and health care worker infections," Journal of Economic Interaction and Coordination, Springer;Society for Economic Science with Heterogeneous Interacting Agents, vol. 12(2), pages 277-307, July.
  52. Laxminarayan, Ramanan & Brown, Gardner M., 2001. "Economics of Antibiotic Resistance: A Theory of Optimal Use," Journal of Environmental Economics and Management, Elsevier, vol. 42(2), pages 183-206, September.
  53. Schober, Thomas, 2020. "Effects of a measles outbreak on vaccination uptake," Economics & Human Biology, Elsevier, vol. 38(C).
  54. Guillaume Morel & Magali Jaoul-Grammare, 2023. "Do Pandemics Impact Macroeconomic Variables? A Cliometric Approach," Working Papers of BETA 2023-01, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
  55. Guillaume Morel & Magali Jaoul-Grammare, 2023. "Do Pandemics Impact Macroeconomic Variables? A Cliometric Approach," Working Papers 01-23, Association Française de Cliométrie (AFC).
  56. Gabriel Picone & Robyn Kibler & Bénédicte H. Apouey, 2017. "Malaria Prevalence, Indoor Residual Spraying, and Insecticide Treated Net Usage in Sub-Saharan Africa," Journal of African Development, African Finance and Economic Association (AFEA), vol. 19(2), pages 19-32.
  57. Kessing, Sebastian G. & Nuscheler, Robert, 2006. "Monopoly pricing with negative network effects: The case of vaccines," European Economic Review, Elsevier, vol. 50(4), pages 1061-1069, May.
  58. Fenichel, Eli P., 2013. "Economic considerations for social distancing and behavioral based policies during an epidemic," Journal of Health Economics, Elsevier, vol. 32(2), pages 440-451.
  59. Yinon Bar-On & Tatiana Baron & Ofer Cornfeld & Eran Yashiv, 2023. "When to Lock, Not Whom: Managing Epidemics Using Time-Based Restrictions," Review of Economic Dynamics, Elsevier for the Society for Economic Dynamics, vol. 51, pages 292-321, December.
  60. Joshua S. Gans, 2023. "Vaccine Hesitancy, Passports, And The Demand For Vaccination," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 64(2), pages 641-652, May.
  61. Barmby, Tim & Larguem, Makram, 2009. "Coughs and sneezes spread diseases: An empirical study of absenteeism and infectious illness," Journal of Health Economics, Elsevier, vol. 28(5), pages 1012-1017, September.
  62. Pichler, Stefan & Ziebarth, Nicolas R., 2015. "The Pros and Cons of Sick Pay Schemes: A Method to Test for Contagious Presenteeism and Shirking Behavior," IZA Discussion Papers 8850, Institute of Labor Economics (IZA).
  63. Goenka, Aditya & Liu, Lin & Nguyen, Manh-Hung, 2014. "Infectious diseases and economic growth," Journal of Mathematical Economics, Elsevier, vol. 50(C), pages 34-53.
  64. Raude, Jocelyn & MCColl, Kathleen & Flamand, Claude & Apostolidis, Themis, 2019. "Understanding health behaviour changes in response to outbreaks: Findings from a longitudinal study of a large epidemic of mosquito-borne disease," Social Science & Medicine, Elsevier, vol. 230(C), pages 184-193.
  65. Stefan Pichler, 2015. "Sickness Absence, Moral Hazard, and the Business Cycle," Health Economics, John Wiley & Sons, Ltd., vol. 24(6), pages 692-710, June.
  66. Stéphane Mechoulan, 2007. "Market structure and communicable diseases," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 40(2), pages 468-492, May.
  67. Matthew Neidell, 2009. "Information, Avoidance Behavior, and Health: The Effect of Ozone on Asthma Hospitalizations," Journal of Human Resources, University of Wisconsin Press, vol. 44(2).
  68. Tut, Daniel, 2021. "Cash Holdings and Firm-Level Exposure to Epidemic Diseases," MPRA Paper 109704, University Library of Munich, Germany.
  69. Christopher S. Carpenter & Emily C. Lawler, 2017. "Direct and Spillover Effects of Middle School Vaccination Requirements," NBER Working Papers 23107, National Bureau of Economic Research, Inc.
  70. Wolf, Christopher A., 2005. "Producer Livestock Disease Management Incentives and Decisions," International Food and Agribusiness Management Review, International Food and Agribusiness Management Association, vol. 8(1), pages 1-16.
  71. Momota, Akira & Tabata, Ken & Futagami, Koichi, 2005. "Infectious disease and preventive behavior in an overlapping generations model," Journal of Economic Dynamics and Control, Elsevier, vol. 29(10), pages 1673-1700, October.
  72. Rat-Aspert, Olivier & Krebs, Stephane, 2013. "Économie des actions collectives de maîtrise des maladies animales endémiques. Proposition d’un cadre d’analyse," Économie rurale, French Society of Rural Economics (SFER Société Française d'Economie Rurale), vol. 338(November-).
  73. Gabriel Picone & Robyn Kibler & Benedicte Apouey, 2013. "Individuals� Preventive Behavioral Response to Changes in Malaria Risks and Government Interventions: Evidence from six African countries," Working Papers 0313, University of South Florida, Department of Economics.
  74. Stéphane Mechoulan, 2006. "Risky Sexual Behavior, Testing and New HIV Treatments," Working Papers tecipa-239, University of Toronto, Department of Economics.
  75. Chakraborty, Shankha & Papageorgiou, Chris & Sebastián, Fidel Pérez, 2016. "Health Cycles And Health Transitions," Macroeconomic Dynamics, Cambridge University Press, vol. 20(1), pages 189-213, January.
  76. Klas Kellerborg & Werner Brouwer & Pieter Baal, 2020. "Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1329-1350, December.
  77. Brahmbhatt, Milan & Dutta, Arindam, 2008. "On SARS type economic effects during infectious disease outbreaks," Policy Research Working Paper Series 4466, The World Bank.
  78. Casey B. Mulligan, 2021. "The Backward Art of Slowing the Spread? Congregation Efficiencies during COVID-19," NBER Working Papers 28737, National Bureau of Economic Research, Inc.
  79. Gersovitz, Mark & Hammer, Jeffrey S., 2005. "Tax/subsidy policies toward vector-borne infectious diseases," Journal of Public Economics, Elsevier, vol. 89(4), pages 647-674, April.
  80. Oster, Emily, 2018. "Does disease cause vaccination? Disease outbreaks and vaccination response," Journal of Health Economics, Elsevier, vol. 57(C), pages 90-101.
  81. Douglas Gollin & Christian Zimmermann, 2007. "Malaria: Disease Impacts and Long-Run Income Differences," Working papers 2007-30, University of Connecticut, Department of Economics, revised Apr 2010.
  82. Lawler, Emily C., 2017. "Effectiveness of vaccination recommendations versus mandates: Evidence from the hepatitis A vaccine," Journal of Health Economics, Elsevier, vol. 52(C), pages 45-62.
  83. Laxminarayan, Ramanan, 2001. "Bacterial Resistance and the Optimal Use of Antibiotics," Discussion Papers 10479, Resources for the Future.
  84. Ibuka, Yoko & Bessho, Shun-ichiro, 2015. "Subsidies for influenza vaccination, vaccination rates, and health outcomes among the elderly in Japan," Japan and the World Economy, Elsevier, vol. 36(C), pages 56-66.
  85. Skatun, John Douglas, 2003. "The overprovision of infectious disease medicine," Economics Letters, Elsevier, vol. 80(1), pages 61-66, July.
  86. Sheikh Shahnawaz, 2011. "Infectious disease outbreak and trade policy formulation," Economics Bulletin, AccessEcon, vol. 31(4), pages 2959-2967.
  87. Imdade Chitou & Gilles Dufrénot & Julien Esposito, 2021. "Linking Covid-19 epidemic and emerging market OAS: Evidence using dynamic copulas and Pareto distributions," Working Papers halshs-03297198, HAL.
  88. Olson, Lars J., 2006. "The Economics of Terrestrial Invasive Species: A Review of the Literature," Agricultural and Resource Economics Review, Cambridge University Press, vol. 35(1), pages 178-194, April.
  89. Ilan Noy & Nguyen Doan & Benno Ferrarini & Donghyun Park, 2019. "Measuring the Economic Risk of Epidemics," CESifo Working Paper Series 8016, CESifo.
  90. Gans, Joshua Samuel, 2020. "The Economic Consequences of R=1: Towards a Workable Behavioural Epidemiological Model of Pandemics," SocArXiv yxdc5, Center for Open Science.
  91. Pichler, Stefan & Ziebarth, Nicolas R., 2019. "Reprint of: The pros and cons of sick pay schemes: Testing for contagious presenteeism and noncontagious absenteeism behavior," Journal of Public Economics, Elsevier, vol. 171(C), pages 86-104.
  92. Auld, M. Christopher, 2003. "Choices, beliefs, and infectious disease dynamics," Journal of Health Economics, Elsevier, vol. 22(3), pages 361-377, May.
  93. Sarkar, Jayanta, 2022. "Do disease prevalence and severity drive COVID-19 vaccine demand?," Economic Analysis and Policy, Elsevier, vol. 75(C), pages 310-319.
  94. Shiv Dixit, 2023. "Contract Enforcement and Preventive Healthcare: Theory and Evidence," Review of Economic Dynamics, Elsevier for the Society for Economic Dynamics, vol. 51, pages 1048-1094, December.
  95. Kuhn, Michael & Wrzaczek, Stefan & Prskawetz, Alexia & Feichtinger, Gustav, 2011. "Externalities in a life cycle model with endogenous survival," Journal of Mathematical Economics, Elsevier, vol. 47(4-5), pages 627-641.
  96. Agüero, Jorge M. & Beleche, Trinidad, 2017. "Health shocks and their long-lasting impact on health behaviors: Evidence from the 2009 H1N1 pandemic in Mexico," Journal of Health Economics, Elsevier, vol. 54(C), pages 40-55.
  97. La Torre, Davide & Liuzzi, Danilo & Marsiglio, Simone, 2021. "Epidemics and macroeconomic outcomes: Social distancing intensity and duration," Journal of Mathematical Economics, Elsevier, vol. 93(C).
  98. Tomas Philipson & Stephane Mechoulan & Anupam Jena, 2006. "Health Care, Technological Change, and Altruistic Consumption Externalities," NBER Working Papers 11930, National Bureau of Economic Research, Inc.
  99. Glenn L. Furton, 2023. "The pox of politics: Troesken’s tradeoff reexamined," Public Choice, Springer, vol. 195(1), pages 169-191, April.
  100. Jens Ludwig & Dave E. Marcotte, 2005. "Anti-depressants, suicide, and drug regulation," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 24(2), pages 249-272.
  101. Toshikazu Kuniya, 2021. "Structure of epidemic models: toward further applications in economics," The Japanese Economic Review, Springer, vol. 72(4), pages 581-607, October.
  102. Hoy, Michael & Polborn, Mattias K., 2015. "The value of technology improvements in games with externalities: A fresh look at offsetting behavior," Journal of Public Economics, Elsevier, vol. 131(C), pages 12-20.
  103. Laxminarayan, Ramanan, 2001. "Bacterial Resistance and the Optimal Use of Antibiotics," RFF Working Paper Series dp-01-23, Resources for the Future.
  104. Jocelyn Raude & Patrick Peretti-Watel & Jeremy Ward & Claude Flamand & Pierre Verger, 2018. "Are Perceived Prevalences of Infection also Biased and How? Lessons from Large Epidemics of Mosquito-Borne Diseases in Tropical Regions," Medical Decision Making, , vol. 38(3), pages 377-389, April.
  105. repec:hal:wpaper:halshs-01222571 is not listed on IDEAS
  106. Yarmand, Hamed & Ivy, Julie S. & Denton, Brian & Lloyd, Alun L., 2014. "Optimal two-phase vaccine allocation to geographically different regions under uncertainty," European Journal of Operational Research, Elsevier, vol. 233(1), pages 208-219.
  107. Davide La Torre & Danilo Liuzzi & Simone Marsiglio, 2022. "Geographical heterogeneities and externalities in an epidemiological‐macroeconomic framework," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 24(5), pages 1154-1181, October.
  108. Battiston, Pietro & Gamba, Simona, 2021. "COVID-19: R0 is lower where outbreak is larger," Health Policy, Elsevier, vol. 125(2), pages 141-147.
  109. Linus Nyiwul, 2021. "Epidemic Control and Resource Allocation: Approaches and Implications for the Management of COVID-19," Studies in Microeconomics, , vol. 9(2), pages 283-305, December.
  110. Laxminarayan, Ramanan & Brown, Gardner M., Jr., 2000. "Economics of Antibiotic Resistance: A Theory of Optimal Use," Discussion Papers 10619, Resources for the Future.
  111. Howard Kunreuther & Geoffrey Heal, 2002. "Interdependent Security: The Case of Identical Agents," NBER Working Papers 8871, National Bureau of Economic Research, Inc.
  112. M. Kate Bundorf & Jill DeMatteis & Grant Miller & Maria Polyakova & Jialu L. Streeter & Jonathan Wivagg, 2021. "Risk Perceptions and Protective Behaviors: Evidence from COVID-19 Pandemic," NBER Working Papers 28741, National Bureau of Economic Research, Inc.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.